In CD4+ T cells, the IL-33/ST2 signaling pathway plays an important role in Th2 activation, and interestingly, IL1RL1 variants are linked to increased risk of IL-33-driven type 2 inflammation in asthma [45]. This evidence concerns the gene IL1RL1 and asthma.